Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.61
-0.01 (-1.79%)
At close: Aug 20, 2025, 9:40 AM
Relmada Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.5 | -0.12 | -0.21 | -0.28 | -0.33 | -0.42 | -0.31 | -0.26 | -0.18 | -0.16 | -0.17 | -1.41 | -0.71 | -0.96 | -0.63 | -0.54 | -1.03 | -1.31 |
PEG Ratio | 0.01 | 0.02 | 0.02 | -0.01 | 0.02 | 0.03 | -0.02 | 0.02 | 0.05 | 0.01 | 0.05 | 0.94 | 0.14 | 0.04 | 0.02 | -0.01 | -0.06 | -0.28 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.25 | 0.37 | 0.44 | 0.51 | 0.38 | 0.51 | 0.36 | 0.22 | 0.17 | 0.14 | 0.19 | 1.34 | 0.58 | 0.73 | 0.41 | 1.26 | 1.13 | 1.28 |
P/FCF Ratio | -3.11 | -0.45 | -1.78 | -1.47 | -1.75 | -2.82 | -3.02 | -1.94 | -1.39 | -1.03 | -0.73 | -8.28 | -5.26 | -7.89 | -2.29 | -4.38 | -6.34 | -7.25 |
P/OCF Ratio | -3.11 | -0.45 | -1.78 | -1.47 | -1.75 | -2.82 | -3.02 | -1.94 | -1.39 | -1.03 | -0.73 | -8.28 | -5.26 | -7.89 | -2.29 | -4.38 | -6.34 | -7.25 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 4.11 | 5.29 | 4.45 | 6.89 | 7.44 | 6.82 | 8.00 | 12.95 | 11.40 | 13.42 | 11.94 | 9.01 | 11.22 | 14.00 | 14.08 | 4.84 | 7.85 | 8.16 |
Current Ratio | 4.11 | 5.29 | 4.45 | 6.89 | 7.44 | 6.82 | 8.00 | 12.95 | 11.40 | 13.42 | 12.26 | 9.01 | 11.40 | 14.65 | 14.83 | 4.98 | 7.95 | 8.16 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.62 | -0.78 | -0.53 | -0.46 | -0.29 | -0.3 | -0.29 | -0.22 | -0.23 | -0.21 | -0.27 | -0.24 | -0.2 | -0.19 | -0.17 | -0.59 | -0.27 | -0.24 |
Return on Assets | -0.47 | -0.63 | -0.41 | -0.39 | -0.25 | -0.26 | -0.26 | -0.2 | -0.21 | -0.19 | -0.25 | -0.21 | -0.19 | -0.18 | -0.15 | -0.47 | -0.24 | -0.21 |
Return on Invested Capital | -0.64 | -0.81 | -0.54 | -0.48 | -0.31 | -0.32 | -0.31 | -0.23 | -0.23 | -0.22 | -0.28 | -0.23 | -0.23 | -0.18 | -0.16 | -0.58 | -0.27 | -0.24 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |